These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10565153)

  • 1. [The immunobiological properties of the lipopolysaccharides of bacteria in the genus Shigella with contrasting virulence and their chemically modified analogs].
    Borisova EV
    Mikrobiol Z; 1999; 61(4):64-71. PubMed ID: 10565153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
    Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipopolysaccharides of Shigella sonnei].
    Borisova EV; Borisov VA
    Prikl Biokhim Mikrobiol; 2000; 36(5):597-602. PubMed ID: 11042887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the structural components of bacterial lipopolysaccharide in its inductive immunosuppressive activity].
    Borisova EV
    Mikrobiol Z; 1999; 61(6):36-41. PubMed ID: 10707531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The inductive immunosuppressive activity of the lipopolysaccharide from Shigella sonnei R forms].
    Borisova EV
    Mikrobiol Z; 1998; 60(3):63-9. PubMed ID: 9785801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in antigenic properties of lipopolysaccharides of Shigella sonnei phase I having lost the virulence due to transposon integration into the invasiveness plasmid PSS120].
    Nikolaeva AI; Nastichkin IA; Romanova IuM; Belova TS; Bondarenko VM; Kabanova EA; Kondrat'eva TK
    Mol Gen Mikrobiol Virusol; 1990 Aug; (8):15-8. PubMed ID: 2172809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive activity of chemically modified lipopolysaccharide of Shigella sonnei.
    Vikström EV
    Immunol Lett; 2002 Jan; 80(1):15-9. PubMed ID: 11716960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. II. Stimulation of the efferent arc.
    Lagrange PH; Mackaness GB
    J Immunol; 1975 Jan; 114(1 Pt 2):447-51. PubMed ID: 1078829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of shigellae on delayed hypersensitivity in mice infected by different routes].
    Borisov VA; Borisova EV; Solov'eva GA
    Mikrobiol Z; 1994; 56(3):55-9. PubMed ID: 7952228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. I. Depression of the afferent arc.
    Lagrange PH; Mackaness GB; Miller TE; Pardon P
    J Immunol; 1975 Jan; 114(1 Pt 2):442-6. PubMed ID: 1090661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunosuppressive activity of Shigella sonnei differing by the presence of plasmid pSS120].
    Borisova EV; Bondarenko VM; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):65-8. PubMed ID: 9460870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonspecific nature of antibody formation suppression by virulent Shigella sonnei].
    Borisov VA; Frolov AF
    Mikrobiol Zh (1978); 1982; 44(1):71-6. PubMed ID: 7040918
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunologic properties of free endotoxin of Shigella sonnei.
    Kowalewska D; Romanowska E; Slopek S; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1970; 18(6):617-29. PubMed ID: 4923971
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of Shigella sonnei strains opposite in their virulence on different links in the immune system].
    Nikolaeva TN; Belaia IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):22-6. PubMed ID: 1279912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipopolysaccharide changes in smooth-type avirulent Shigella in comparison with initial virulent strains].
    Nikolaeva AI; Nastichkin IA; Kabanova EA; Lapina EB; Krukovets IL
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):15-8. PubMed ID: 1441805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of bacterial antigens on lymphocyte immune receptors in mice].
    Burlakov GV
    Biull Eksp Biol Med; 1989 Dec; 108(12):707-10. PubMed ID: 2699437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on the immunologic properties of free endotoxin and lipopolysaccharide from Shigella sonnei.
    Kowalewska D; Romanowska E
    Arch Immunol Ther Exp (Warsz); 1977; 25(3):323-30. PubMed ID: 329799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioluminescent signal system: bioluminescence immunoassay of pathogenic organisms.
    Frank L; Markova S; Remmel N; Vysotski E; Gitelson I
    Luminescence; 2007; 22(3):215-20. PubMed ID: 17286244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.